These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 25271142)
1. Retrospective Analysis of Dose Titration and Serum Testosterone Level Assessments in Patients Treated With Topical Testosterone. Muram D; Kaltenboeck A; Boytsov N; Hayes-Larson E; Ivanova J; Birnbaum HG; Swindle R Am J Mens Health; 2015 Nov; 9(6):496-505. PubMed ID: 25271142 [TBL] [Abstract][Full Text] [Related]
2. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
3. Long-term treatment patterns of testosterone replacement medications. Donatucci C; Cui Z; Fang Y; Muram D J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541 [TBL] [Abstract][Full Text] [Related]
4. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: a retrospective medical claims analysis. Schoenfeld MJ; Shortridge E; Cui Z; Muram D J Sex Med; 2013 May; 10(5):1401-9. PubMed ID: 23464534 [TBL] [Abstract][Full Text] [Related]
5. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364 [TBL] [Abstract][Full Text] [Related]
6. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. Taylor F; Levine L J Sex Med; 2010 Jan; 7(1 Pt 1):269-76. PubMed ID: 19694928 [TBL] [Abstract][Full Text] [Related]
7. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433 [TBL] [Abstract][Full Text] [Related]
8. 12-month observation of testosterone replacement effectiveness in a general population of men. Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767 [TBL] [Abstract][Full Text] [Related]
9. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men. Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709 [TBL] [Abstract][Full Text] [Related]
10. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. Grabner M; Hepp Z; Raval A; Tian F; Khera M J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664 [TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768 [TBL] [Abstract][Full Text] [Related]
12. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan. Shortridge EF; Polzer P; Donga P; Wade RL Int J Clin Pract; 2015 Jul; 69(7):783-90. PubMed ID: 25854747 [TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Morrison BF; Reid M; Madden W; Burnett AL Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509 [TBL] [Abstract][Full Text] [Related]
14. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel. Burns PR; Kim ED; Ruff DD; Seftel AD Am J Mens Health; 2018 May; 12(3):524-530. PubMed ID: 26438471 [TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems. Bhatia R; Murphy AB; Raper JL; Chamie G; Kitahata MM; Drozd DR; Mayer K; Napravnik S; Moore R; Achenbach C; AIDS; 2015 Jan; 29(1):77-81. PubMed ID: 25387318 [TBL] [Abstract][Full Text] [Related]
17. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. Reyes-Vallejo L; Lazarou S; Morgentaler A J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806 [TBL] [Abstract][Full Text] [Related]
18. The appropriateness and persistence of testosterone replacement therapy in Ontario. Martins D; Yao Z; Tadrous M; Shah BR; Juurlink DN; Mamdani MM; Gomes T; Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):119-126. PubMed ID: 27528454 [TBL] [Abstract][Full Text] [Related]
19. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System. Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440 [TBL] [Abstract][Full Text] [Related]
20. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism. Smith RP; Khanna A; Coward RM; Rajanahally S; Kovac JR; Gonzales MA; Lipshultz LI J Sex Med; 2013 Sep; 10(9):2326-33. PubMed ID: 23859250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]